Advances in artificial intelligence (AI) could potentially reduce the complexities and costs in drug discovery. Using a … affect a firm’s discovery of new drug-target pairs for preclinical studies. The effect is particularly pronounced for … and domain expertise in drug discovery as opposed to employees possessing AI skills only. Having the combination is key …

high. Under current doctrine, a generic drugmaker is liable for induced infringement if its drug label so much as hints at … generic drug labels and in cases when only an in-depth inquiry into the language of the label might promote infringement. As I … because it unconstitutionally prolongs drug monopolies and undermines a key statutory path to generic competition. Revisiting …

This volume is part of the response to the 2016 UN General Assembly Special Session (UNGASS) on international drug … policy and the emergence of analysis of international drug policy in academic literature. Editors David Bewley-Taylor and …-Western countries. They have selected authors to provide an analytical critique of international drug policy, evidencing their stance of …